BIIB

BIIB Total Current Assets

$7.31BQuarterly · USD

Period ending:

BIIB FY Current AssetsUSD
BIIB FY Current Assets1985-12-31: $57.00M1986-12-31: $73.60M1987-12-31: $57.80M1988-12-31: $57.60M1989-12-31: $119.60M1990-12-31: $120.80M1991-12-31: $209.20M1992-12-31: $268.40M1993-12-31: $309.40M1994-12-31: $294.78M1995-12-31: $340.31M1996-12-31: $435.75M1997-12-31: $596.07M1998-12-31: $694.14M1999-12-31: $910.23M2000-12-31: $928.27M2001-12-31: $1.10B2002-12-31: $1.22B2003-12-31: $1.84B2004-12-31: $1.93B2005-12-31: $1.62B2006-12-31: $1.71B2007-12-31: $2.37B2008-12-31: $2.46B2009-12-31: $2.48B2010-12-31: $2.54B2011-12-31: $2.98B2012-12-31: $3.24B2013-12-31: $3.18B2014-12-31: $4.67B2015-12-31: $6.70B2016-12-31: $8.73B2017-12-31: $7.87B2018-12-31: $7.64B2019-12-31: $8.38B2020-12-31: $6.89B2021-12-31: $7.86B2022-12-31: $9.79B2023-12-31: $6.86B2024-12-31: $7.46B2025-12-31: $8.97B$9.79B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BIIB total current assets history

Assets expected to be converted to cash within one year. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Biogen Total Current Assets — Annual fiscal periods (USD)
Period endingTotal Current Assets (USD)
8,974,100,000
7,456,800,000
6,859,300,000
9,791,200,000
7,856,500,000
6,887,100,000
8,381,800,000
7,640,900,000
7,873,300,000
8,732,200,000
6,700,300,000
4,672,673,000
3,184,934,000
3,244,337,000
2,975,427,000
2,540,420,000
2,480,595,000
2,458,000,000
2,368,407,000
1,712,567,000
1,618,081,000
1,931,044,000
1,838,664,000
1,216,024,000
1,097,727,000
928,271,000
910,226,000
694,144,000
596,066,000
435,754,000
340,309,000
294,784,000
309,400,000
268,400,000
209,200,000
120,800,000
119,600,000
57,600,000
57,800,000
73,600,000
57,000,000

Compare total current assets

All BIIB financial metrics · BIIB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.